It may surprise many to hear that some of today’s most advanced treatments, such as cell therapies for cancer, diabetes, and autoimmunity, depend on flow cytometry — a 50-year old technology.

In a recent paper, scientists from the Fred Hutchinson Cancer Center, ETH Zurich, and BD Biosciences described an experiment in which a flow cytometry system was used to analyze blood samples and ...

October is Breast Cancer Awareness Month, and fittingly, University of New Mexico Comprehensive Cancer Center biologist Curt ...

SAN ANTONIO, October 16, 2024--(BUSINESS WIRE)--bioAffinity Technologies’ (Nasdaq: BIAF; BIAFW) Vice President of Diagnostics, Jennifer Rebeles, Ph.D., was part of a panel of worldwide experts ...

Research uncovers how P-stalk ribosomes regulate cytokine responses, driving immune evasion in tumors across multiple cancer types. It offers new insights into post-translational mechanisms ...

“Our CyPath® Lung noninvasive test for the early detection of lung cancer is a novel test that uses sputum, a unique sample type that is not typically used in clinical flow cytometry assays ...

High Content Screening MarketThe global high content screening (HCS) market is set to experience impressive growth, with its market value expected to soar beyond USD 3 billion by 2033, up from over ...

We performed integration-site analysis, genetic studies, flow cytometry, and morphologic studies ... features of seven cases of hematologic cancer (as of April 25, 2024) in patients who received ...

(2024-10-16 | NDAQ:BIAF) bioAffinity's CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry Guidelines ...

A recent study released by researchers at North Carolina State University offers new insights and guidelines for the accurate estimation of plant genome size using flow cytometry. Flow cytometry ...